Prepaid and Other Assets (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
| Prepaid operating expenses, non-clinical | $ 28,312 | $ 19,465 |
| Production campaign deposits | 23,781 | 15,127 |
| Clinical trial advances | 17,076 | 11,630 |
| Prefunded customer programs | 4,567 | 3,514 |
| Total | 73,736 | 49,736 |
| Less: Current portion | (66,048) | (42,443) |
| Total other assets | $ 7,688 | $ 7,293 |
| X | ||||||||||
- Definition Clinical Trial Advances No definition available.
|
| X | ||||||||||
- Definition Prefunded Customer Program No definition available.
|
| X | ||||||||||
- Definition Prepaid Operating Expenses, Non-Clinical No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncurrent assets classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|